ORGANOGENESIS HOLDINGS INC. Preferred Stock, Shares Outstanding
ORGANOGENESIS HOLDINGS INC. (ORGO) had Preferred Stock, Shares Outstanding of 0 shares as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:PreferredStockSharesOutstanding · last filed 2026-08-06
- 2026-06-30: Preferred Stock, Shares Outstanding 0.00 shares.
- 2025-12-31: Preferred Stock, Shares Outstanding 0.00 shares.
- 2025-09-30: Preferred Stock, Shares Outstanding 0.00 shares.
- 2025-06-30: Preferred Stock, Shares Outstanding 0.00 shares.
| Period end | Preferred Stock, Shares Outstanding |
|---|---|
| 2026-06-30 | 0.00 shares 10-Q · filed 2026-08-06 |
| 2025-12-31 | 0.00 shares 10-Q · filed 2026-08-06 |
| 2025-09-30 | 0.00 shares 10-Q · filed 2025-11-06 |
| 2025-06-30 | 0.00 shares 10-Q · filed 2025-08-07 |
| 2025-03-31 | 0.00 shares 10-Q · filed 2025-05-08 |
| 2024-12-31 | 0.00 shares 10-K · filed 2026-02-26 |
| 2023-12-31 | 0.00 shares 10-K · filed 2025-02-27 |
| 2018-09-30 | 0.00 shares 10-Q · filed 2018-11-09 |
| 2018-06-30 | 0.00 shares 10-Q · filed 2018-08-07 |
| 2018-03-31 | 0.00 shares 10-Q · filed 2018-05-10 |
| 2017-12-31 | 0.00 shares 10-Q · filed 2018-11-09 |
| 2017-09-30 | 0.00 shares 10-Q · filed 2017-11-14 |
| 2017-06-30 | 0.00 shares 10-Q · filed 2017-08-11 |
| 2017-03-31 | 0.00 shares 10-Q · filed 2017-05-12 |
| 2016-12-31 | 0.00 shares 10-K · filed 2018-03-14 |
| 2016-09-30 | 0.00 shares 10-Q · filed 2016-11-18 |
| 2015-12-31 | 0.00 shares 10-K · filed 2018-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |